The typical case for the fund is to invest in rounds with 2 participants. Despite the VitaTech S.A, startups are often financed by Venture Kick. The meaningful sponsors for the fund in investment in the same round are TiVenture, Helsinn Investment Fund.
The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2019.
We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Gain Therapeutics.
| Fund Name | Location |
| 2 Welten Investment | Germany, Hamburg |
| Acuta Capital Partners | - |
| Bank OZK | Arkansas, Little Rock, United States |
| Ceres Partners | Indiana, South Bend, United States |
| CityRock Venture Partners | New York, New York, United States |
| Coinsilium Group | England, London, United Kingdom |
| CRS Recycling Services | - |
| FreeBit Co, Ltd | Chiyoda, Japan |
| Gabriel Capital Management | New York, New York, United States |
| Greater Manchester AI Foundry | England, Manchester, United Kingdom |
| Kardan | Amsterdam, Noord-Holland, The Netherlands |
| Kettle Partners | Chicago, Illinois, United States |
| Mubadala Investment Company | California, San Francisco, United States |
| Pomegranate Investment AB | - |
| Sphera Funds Management | Israel, Tel Aviv, Tel Aviv District |
| The Coca-Cola Company | Atlanta, Georgia, United States |
| TNP Threads Of Light | Japan, Kanagawa Prefecture, Yokohama |
| TPG Growth | California, San Francisco, United States |
| Yuanlu Investment Management | China, Shanghai |
| Zhejiang Daily Digital Culture | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aesyra | 25 Jun 2019 | Lausanne, Vaud, Switzerland | |||
Industrie Biomediche Insubri | 31 May 2019 | Ticino, Ticino, Switzerland | |||
Gain Therapeutics | $2M | 19 Feb 2019 | Bethesda, Maryland, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aesyra | 25 Jun 2019 | Lausanne, Vaud, Switzerland | |||
Industrie Biomediche Insubri | 31 May 2019 | Ticino, Ticino, Switzerland | |||
Gain Therapeutics | $2M | 19 Feb 2019 | Bethesda, Maryland, United States |
